SHL Medical AG

SHL Medical AG is a pioneering leader in designing, developing, and manufacturing self-injection solutions, including autoinjectors, pen injectors, and innovative specialty delivery systems for large-volume and high-viscosity formulations. Headquartered in 146 with sites across three continents, SHL offers end-to-end services, from design and development to final assembly, labeling, and packaging. By partnering with pharmaceutical companies, SHL delivers self-injection systems that enable patients' independence, improving treatment adherence and overall healthcare outcomes. SHL's product portfolio includes the Molly® platform, a modular autoinjector system known for its versatility and user-friendly design. The Maggie® series caters to large-volume injections, while the Elexy™ platform represents a new generation of electromechanical autoinjectors with advanced features. These devices are designed to accommodate various drug formulations and patient needs, ensuring a seamless and comfortable injection experience. With over 30 years of industry experience, SHL Medical has helped shape how autoinjectors transform the way medications are delivered, particularly in the realm of biologic therapies. The company's commitment to innovation and quality has established it as a trusted partner in the global pharmaceutical and biotechnology sectors.